Drug General Information
Drug ID
D0G2MW
Former ID
DAP000969
Drug Name
Icosapent
Synonyms
Icosapento; Icosapentum; Eicosapentaenoic acid; Icosapentaenoic acid; Timnodonic acid; E0441; BML3-B01; Icosapento [INN-Spanish]; Icosapentum [INN-Latin]; EICOSAPENTAENOIC ACID (20:5 n-3); All cis-5,8,11,14,17-Eicosapentaenoic Acid; All cis-5,8,11,14,17-Icosapentaenoic Acid; Cis-5,8,11,14,17-EPA; Cis-5,8,11,14,17-Eicosapentaenoic acid; Cis-Delta(5,8,11,14,17)-eicosapentaenoic acid; All-cis-icosa-5,8,11,14,17-pentaenoic acid; Cis, cis, cis, cis, cis-eicosa-5,8,11,14,17-pentaenoic acid; (5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-eicosapentaenoic acid; (5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate; (5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid; (5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid; (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid; (Z,Z,Z,Z,Z)-5,8,11,14,17-eicosapentaenoic acid; (all-Z)-5,8,11,14,17-Eicosapentaenoic acid; (all-Z)-delta5,8,11,14,17-Eicosapentaenoic acid; (all-cis)-5,8,11,14,17-Eicosapentaenoic acid; 5,8,11,14,17-EICOSAPENTAENOIC ACID; 5,8,11,14,17-Eicosapentaenoic acid (6CI); 5,8,11,14,17-Eicosapentaenoic acid, (5Z,8Z,11Z,14Z,17Z)-(9CI); 5,8,11,14,17-Eicosapentaenoic acid, (all-Z)-(8CI); 5,8,11,14,17-Icosapentaenoic acid; 5Z,8Z,11Z,14Z,17Z-Eicosapentaenoic acid; 7F8BF016-B146-4F72-A52E-B9298BA3A9AB
Drug Type
Small molecular drug
Indication Hyperglyceridemic [ICD9: 790.29; ICD10:R73.9] Approved [542465], [550112]
Therapeutic Class
Dietary supplement
Structure
Download
2D MOL

3D MOL

Formula
C22H34O2
InChI
InChI=1S/C22H34O2/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24-4-2/h5-6,8-9,11-12,14-15,17-18H,3-4,7,10,13,16,19-21H2,1-2H3/b6-5-,9-8-,12-11-,15-14-,18-17-
InChIKey
SSQPWTVBQMWLSZ-AAQCHOMXSA-N
CAS Number
CAS 10417-94-4
PubChem Compound ID
PubChem Substance ID
ChEBI ID
ChEBI:28364
Target and Pathway
Target(s) Cyclooxygenase Target Info Binder [535691]
References
Ref 542465(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7441).
Ref 550112Drug information of Icosapent, Health Canada, 2007.
Ref 535691Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J Lipid Res. 2003 Mar;44(3):479-86. Epub 2002 Dec 1.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.